We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BNZL:LSEBunzl plc Analysis

Data as of 2026-06-12 - not real-time

£2,538.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Technical momentum remains bullish – the price of £25.38 is above the 20‑day (£24.17), 50‑day (£23.85) and 200‑day (£22.75) SMAs, RSI sits at 64.6 and MACD is firmly in bullish territory. However, the DCF fair‑value of £18.11 and the recent analyst note nudging fair value to the mid‑£24s indicate the stock is currently priced above intrinsic value. The dividend yield of 2.9% with a 52.5% payout ratio appears sustainable given solid operating cash flow and a ROE of 16.5%. Volatility over the past 30 days is ~24% but beta is extremely low (≈0.06), suggesting limited market‑wide risk. Recent news highlights dividend‑seeking investors needing to act quickly and reiterates the modest fair‑value estimate, reinforcing the view that the share price is stretched.
Given the defensive consumer sector positioning, diversified geography and strong cash generation, the stock offers a stable income platform, but upside potential is limited until valuation compresses. Investors should weigh the attractive dividend against the overvaluation and consider a wait‑and‑see stance for longer horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (price above SMAs, RSI 64, MACD bullish)
  • Current price exceeds DCF fair value and analyst fair‑value range
  • Strong dividend yield but limited upside near 52‑week high

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Stable cash flow and sustainable dividend payout
  • Defensive consumer sector with low beta
  • Valuation gap may persist, limiting price appreciation

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Low systematic risk and defensive industry positioning
  • Attractive dividend yield with solid payout coverage
  • Diversified geographic exposure reducing concentration risk

Key Metrics & Analysis

Financial Health

Revenue Growth0.30%
Profit Margin3.88%
P/E Ratio18.0
ROE16.47%
ROA5.24%
Debt/Equity105.93
P/B Ratio2.9
Op. Cash Flow£913.0M
Free Cash Flow£622.8M

Technical Analysis

TrendBullish
RSI64.6
Support£2,276.00
Resistance£2,614.00
MA 20£2,417.30
MA 50£2,384.88
MA 200£2,274.65
MACDBullish
VolumeStable
Fear & Greed Index88.96

Valuation

Fair Value£1,811.20
Target Price£2,489.50
Upside/Downside-1.91%
GradeOvervalued
TypeValue
Dividend Yield2.90%

Risk Assessment

Beta0.06
Volatility24.39%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.